INTERSTITIAL CYSTITIS AND CANNABIDIOL

Interstitial Cystitis is a fairly common disorder in both men and women. The cause is not well understood but the syndrome consists of urinary urgency, frequency and pain. This syndrome can be devastating for patients and become a part of a chronic pelvic pain syndrome, which I will cover in a future blog.

I see these patients generally referred by their urologist, gynecologist or pain specialist. I had one patient referred by their psychiatrist as they were nearly suicidal due to the pain and urgency.

I find that mostly using just Whole Plant CBD or WP-CBD in modest doses to be very effective.

With this and many other conditions, it is not unusual for the modest WP-CBD dose to take 1-2 weeks to become fully effective.

So, with this syndrome and many others, don’t be too quick to raise the dose. When in doubt, give it a little more time.

Author
Allan Frankel, MD Dr Allan Frankel is one of the few physicians in the US who truly understands Cannabis as a medicine. All treatments suggested have been well studied. Every patient seen by Dr Frankel is given a personally created Treatment Plan created with the patient's specific issues defined. Plant medicine requires "tuning" of the dosing. Dr Frankel works with his patients thru a messaging portal. The use of this portal, allows quick and simple follow up contact with Dr Frankel. Patients are not charged for these messages, as this is how Dr Frankel has learned what he has learned. Follow up appointments in person or by phone/video are also available when needed

You Might Also Enjoy...

Rationing Health Care

With COVID, we have never been more aware of critical shortages of masks, ventilators, hospital beds, etc., all leading to rationing. In this BLOG, Dr Frankel, examines how rationing in our medical care is a much bigger problem than just face masks.

Cannabis May Prevent COVID-19 Infections

Early studies in both Israel and Canada show findings consistent with CBD's effect on COVID-19's ability to take hold in the lungs or the gastrointestinal tract. If the receptors are reduced, the viral infection and pulmonary toxicity should be reduced.